\-\ Texto\\:\\ \ \(0\)\
\-\ negative\\ pe\ \(0\)\
\-\ labs\\-n\\/a\ \(0\)\
\-\ observation\ \(85\)\
\-\ ap\\/lat\\ femur\\:\\ \\ 2\\ cm\\ and\\ 1\\.5\\ cm\\ well\\ defined\\,\\ irregular\\ sclerotic\\ lesions\\ in\\ the\\ central\\ diaphysis\\ of\\ the\\ right\\ femur\\.\\ there\\ is\\ a\\ narrow\\ transition\\ zone\\ with\\ no\\ cortical\\ destruction\\,\\ endosteal\\ scalloping\\ or\\ peristeal\\/soft\\ tissue\\ changes\\.\ \(0\)\
\-\ mri\\:\\ clustered\\ nodules\\ with\\ irregular\\ shape\\ having\\ high\\ t2\\ signal\\ intensity\\ and\\ lobulated\\ border\\ with\\ areas\\ of\\ low\\ signal\\ consistent\\ with\\ chondroid\\ calcified\\ matrix\\.\\ \\ no\\ endosteal\\,\\ periosteal\\ or\\ soft\\ tissue\\ changes\\ seen\\.\ \(0\)\
\-\ enchondroma\ \(73\)\
\-\ 1\\)echondroma\ \(0\)\
\-\ 2\\)bone\\ infarct\\ \\(no\\ serpiginous\\ sclerotic\\ border\\)\ \(0\)\
\-\ 3\\)low\\-grade\\ chondrosarcoma\\ \\(not\\ axial\\,\\ epiphyseal\\,\\ or\\ proximal\\ location\\;\\ not\\ painful\\;\\ not\\ large\\;\\ no\\ destructive\\ cortical\\ changes\\)\ \(1\)\
\-\ 29\\ y\\/o\\ male\\ with\\ thigh\\ injury\\ with\\ incidental\\ finding\\ on\\ xray\\ of\\ enchondroma\\.\ \(1\)\
\-\ the\\ findings\\ of\\ this\\ case\\ are\\ typical\\ for\\ enchondroma\\.\\ \\ not\\ being\\ at\\ a\\ higher\\ risk\\ location\\,\\ asymptomatic\\,\\ not\\ large\\ and\\ no\\ destructive\\ cortical\\ or\\ soft\\ tissue\\ changes\\ all\\ favor\\ enchondroma\\ vs\\.\\ chondrosarcoma\\.\\ \\ observation\\ and\\ periodic\\ follow\\-up\\ radiographs\\ to\\ assess\\ stability\\ is\\ warranted\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ enchondroma\\:\\ 0\\.3725966142942685\ \(0\)\
\-\ changes\\:\\ 0\\.2129692611786653\ \(0\)\
\-\ endosteal\\:\\ 0\\.19917518746563287\ \(0\)\
\-\ cortical\\:\\ 0\\.1897439935129616\ \(0\)\
\-\ destructive\\:\\ 0\\.18773520227029422\ \(0\)\
\-\ not\\:\\ 0\\.1738935296276833\ \(0\)\
\-\ observation\\:\\ 0\\.16524160816032418\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.1615641413444015\ \(0\)\
\-\ border\\:\\ 0\\.1558277705062111\ \(0\)\
\-\ sclerotic\\:\\ 0\\.14780459509483285\ \(0\)\
\-\ femur\\:\\ 0\\.14455025373109526\ \(0\)\
\-\ no\\:\\ 0\\.143241146143504\ \(0\)\
\-\ echondroma\\:\\ 0\\.14088671090340216\ \(0\)\
\-\ soft\\:\\ 0\\.14070333289895945\ \(0\)\
\-\ tissue\\:\\ 0\\.13864152385297082\ \(0\)\
\-\ irregular\\:\\ 0\\.13602996226001923\ \(0\)\
\-\ location\\:\\ 0\\.1226896259305288\ \(0\)\
\-\ or\\:\\ 0\\.1225898838448764\ \(0\)\
\-\ clustered\\:\\ 0\\.11765798401254143\ \(0\)\
\-\ serpiginous\\:\\ 0\\.10611812621916364\ \(0\)\
\-\ favor\\:\\ 0\\.10532596091622468\ \(0\)\
\-\ chondroid\\:\\ 0\\.10457245354959507\ \(0\)\
\-\ with\\:\\ 0\\.10350327911529841\ \(0\)\
\-\ cm\\:\\ 0\\.10119052111162852\ \(0\)\
\-\ low\\:\\ 0\\.10110137913061201\ \(0\)\
\-\ signal\\:\\ 0\\.0998796734120584\ \(0\)\
\-\ periodic\\:\\ 0\\.09906402367801828\ \(0\)\
\-\ warranted\\:\\ 0\\.09855762298295602\ \(0\)\
\-\ epiphyseal\\:\\ 0\\.09759206874980869\ \(0\)\
\-\ xray\\:\\ 0\\.09759206874980869\ \(0\)\
\-\ scalloping\\:\\ 0\\.095825133878843\ \(0\)\
\-\ transition\\:\\ 0\\.09213050943770304\ \(0\)\
\-\ stability\\:\\ 0\\.08888274131836847\ \(0\)\
\-\ matrix\\:\\ 0\\.08861873766755352\ \(0\)\
\-\ large\\:\\ 0\\.08828220914518668\ \(0\)\
\-\ thigh\\:\\ 0\\.08665497380112157\ \(0\)\
\-\ narrow\\:\\ 0\\.0864261720238292\ \(0\)\
\-\ diaphysis\\:\\ 0\\.08575942801737604\ \(0\)\
\-\ zone\\:\\ 0\\.08512028146439506\ \(0\)\
\-\ shape\\:\\ 0\\.08353490739123577\ \(0\)\
\-\ assess\\:\\ 0\\.08142565702325508\ \(0\)\
\-\ lobulated\\:\\ 0\\.0812622286464341\ \(0\)\
\-\ destruction\\:\\ 0\\.08031639205080945\ \(0\)\
\-\ higher\\:\\ 0\\.0800135620052253\ \(0\)\
\-\ painful\\:\\ 0\\.07791388525310555\ \(0\)\
\-\ periosteal\\:\\ 0\\.07752615348707596\ \(0\)\
\-\ 29\\:\\ 0\\.07677872517484162\ \(0\)\
\-\ having\\:\\ 0\\.07595012138667362\ \(0\)\
\-\ infarct\\:\\ 0\\.07330823055739906\ \(0\)\
\-\ pe\\:\\ 0\\.07283005497678781\ \(0\)\
\-\ and\\:\\ 0\\.07281688772447041\ \(0\)\
\-\ calcified\\:\\ 0\\.07096923630611349\ \(0\)\
\-\ nodules\\:\\ 0\\.06999862349529508\ \(0\)\
\-\ of\\:\\ 0\\.06896098190660892\ \(0\)\
\-\ typical\\:\\ 0\\.0680840811893214\ \(0\)\
\-\ vs\\:\\ 0\\.06720903283865759\ \(0\)\
\-\ incidental\\:\\ 0\\.06530300301139377\ \(0\)\
\-\ risk\\:\\ 0\\.06294713434572746\ \(0\)\
\-\ defined\\:\\ 0\\.06284813504844439\ \(0\)\
\-\ intensity\\:\\ 0\\.06255488881742936\ \(0\)\
\-\ being\\:\\ 0\\.061389642713699635\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.05997493268155464\ \(0\)\
\-\ areas\\:\\ 0\\.05981193552218728\ \(0\)\
\-\ central\\:\\ 0\\.05883042120276777\ \(0\)\
\-\ finding\\:\\ 0\\.0579075757667625\ \(0\)\
\-\ injury\\:\\ 0\\.05744863939729275\ \(0\)\
\-\ radiographs\\:\\ 0\\.05713871921468016\ \(0\)\
\-\ proximal\\:\\ 0\\.05503817573205584\ \(0\)\
\-\ negative\\:\\ 0\\.05454041655777769\ \(0\)\
\-\ the\\:\\ 0\\.05273579162636332\ \(0\)\
\-\ all\\:\\ 0\\.052442204949543166\ \(0\)\
\-\ axial\\:\\ 0\\.05088815027841646\ \(0\)\
\-\ t2\\:\\ 0\\.05068479029925167\ \(0\)\
\-\ lesions\\:\\ 0\\.05059526055581426\ \(0\)\
\-\ high\\:\\ 0\\.050068715096423196\ \(0\)\
\-\ is\\:\\ 0\\.04825207093557532\ \(0\)\
\-\ bone\\:\\ 0\\.04806861542017835\ \(0\)\
\-\ consistent\\:\\ 0\\.047768361248755914\ \(0\)\
\-\ mri\\:\\ 0\\.04522132068502326\ \(0\)\
\-\ case\\:\\ 0\\.04425910963567335\ \(0\)\
\-\ findings\\:\\ 0\\.0434795355253058\ \(0\)\
\-\ well\\:\\ 0\\.04265713161278632\ \(0\)\
\-\ seen\\:\\ 0\\.04147548062714279\ \(0\)\
\-\ male\\:\\ 0\\.039224292814870575\ \(0\)\
\-\ there\\:\\ 0\\.035053629664358335\ \(0\)\
\-\ are\\:\\ 0\\.03342890669427717\ \(0\)\
\-\ at\\:\\ 0\\.03327545353334891\ \(0\)\
\-\ this\\:\\ 0\\.030271807902763716\ \(0\)\
\-\ right\\:\\ 0\\.029207889552201414\ \(0\)\
\-\ for\\:\\ 0\\.02670160591487361\ \(0\)\
\-\ on\\:\\ 0\\.02660688720342471\ \(0\)\
\-\ to\\:\\ 0\\.02202414403494485\ \(0\)\
\-\ in\\:\\ 0\\.02191574124361842\ \(0\)\
